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 
Abstract— Quantitative assessment of movement 
impairment in Huntington’s disease (HD) is essential to 
monitoring of disease progression. This study aimed to 
develop and validate a novel low cost, objective automated 
system for the evaluation of upper limb movement 
impairment in HD in order to eliminate the inconsistency of 
the assessor and offer a more sensitive, continuous 
assessment scale. Patients with genetically confirmed HD 
and healthy controls were recruited to this observational 
study. Demographic data including age (years), gender and 
Unified Huntington’s Disease Rating Scale Total Motor 
Score (UHDRS-TMS) were recorded. For the purposes of 
this study a modified upper limb motor impairment score 
(mULMS) was generated from the UHDRS-TMS. All 
participants completed a brief, standardized clinical 
assessment of upper limb dexterity whilst wearing a tri-
axial accelerometer on each wrist and on the sternum. The 
captured acceleration data were used to develop an 
automatic classification system for discriminating between 
healthy and HD participants and to automatically generate 
a continuous Movement Impairment Score (MIS) that 
reflected the degree of the movement impairment. Data 
from 48 healthy and 44 HD participants was used to validate 
the developed system, which achieved 98.78% accuracy in 
discriminating between healthy and HD participants. The 
Pearson correlation coefficient between the automatic MIS 
and the clinician rated mULMS was 0.77 with a p-value < 
0.01. The approach presented in this study demonstrates 
the possibility of an automated objective, consistent and 
sensitive assessment of the HD movement impairment.  
 
Index Terms— accelerometers, upper-limb assessment, 
Huntington’s disease, movement disorder. 
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I. Introduction 
UNTINGTON’S disease (HD) is an autosomal dominant, 
progressive neurodegenerative genetic disorder, which 
affects 11.2 to 13.5 people per 100,000 of the general 
population. HD is characterised by the development of 
progressive motor impairment, cognitive decline and 
behavioural problems [1], [2], caused by an expanded 
trinucleotide CAG sequence in the Huntingtin (HTT) gene [2]-
[4].  
One of the most prominent motor symptoms in HD is chorea, 
which is used to describe abnormal involuntary movement 
characterized by abrupt, irregular, unpredictable, non-
stereotyped movements, However, other motor abnormalities 
such as dyskinesia, dystonia, rigidity, and bradykinesia are also 
seen. A critical problem for the evaluation of novel therapeutics 
is the acknowledged lack of objective clinical measures suitable 
for evaluating the components of the movement disorder. The 
Unified Huntington’s Disease Rating Scale (UHDRS) [5] is 
currently the gold standard to assess disease symptoms in HD. 
However, UHDRS assessment is limited by inter- and intra-
rater variability, subjective bias, and categorical design. 
Furthermore, the UHDRS score does not relate motor 
impairment to function in daily life, which is desirable in HD 
assessment [6].  
Over the past twenty years there has been significant 
progression in human motion recording and analysis over a 
wide range of applications, including orthopaedic and 
neurological rehabilitation. Such analysis requires highly 
accurate motion tracking made possible using, for example, 
camera-based systems (e.g. Qualisys, Sweden and Vicon, UK). 
Unfortunately such systems are expensive, difficult to transport, 
and require dedicated laboratory space, although low-cost but 
less accurate motion capture devices such as Kinect are also 
becoming popular in motion analysis research [7]. 
More recently, there have been a number of attempts to 
evaluate chorea, dystonia and bradykinesia in people with 
movement disorders using Inertial Measurement Units (IMUs) 
or electromagnetic motion sensors [6], [8]-[13]. The majority 
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have relied on statistical methods to assess movement 
impairment [10], [11], however more recently machine-
learning techniques are being applied to the data to achieve 
automated assessment of the presence or absence of the 
symptoms or their severity [9], [13]-[15]. Application of 
machine learning methods for wearable sensor data in 
Parkinson’s disease (PD) was advocated and explained in detail 
in a recent review where the possibility of using wearable 
sensor data for clinical PD measurement was also highlighted 
[16]. Specifically, the main stages in applying machine learning 
techniques to the analysis of the sensor data were identified as 
feature extraction, which summarises sensor data into a small 
set of features; dimensionality reduction, which further reduces 
the number of features for ease of analysis and to retain only the 
most significant information; and supervised or unsupervised 
learning which finds patterns in the sensor data.  In particular, 
supervised learning learns a model (relationship) between 
inputs (a set of feature values) and outputs (for example, 
symptom severity classification) from a set of examples, and 
uses this model to predict outputs given a new set of input 
values. At the same time, common pitfalls of machine learning 
such as overfitting and underfitting a model were noted along 
with possible remedies, such as model complexity control 
through the use of, for example, cross-validation model testing.  
There has been a fair amount of research in the area of 
applying machine learning methods for the automatic 
assessment of the movement disorders associated with PD, 
particularly tremor and bradykinesia [14], [15], [17]-[19]. At 
the same time, there were only two reports on the application of 
these methods in HD [9], [13]. In the two latter studies, machine 
learning techniques were used to automatically classify people 
into HD and healthy controls groups based on gait analysis [9] 
or arm movements [13] and data from IMUs. However, these 
studies are still falling short of proposing an automatic system 
capable of assessing HD movement impairment using a more 
sensitive, continuous scale necessary for monitoring the disease 
progression. 
The aim of this study was to apply signal processing and 
machine learning techniques in the development and validation 
of a low cost, objective automated system for the evaluation of 
upper limb movement impairment in HD.  Data from 48 healthy 
and 44 manifest stage HD participants were collected and used 
to design and validate the proposed system.  Signal processing 
techniques were used to extract time and frequency domain 
features from the acceleration signals; a feature selection 
method was used to determine the features important for 
distinguishing HD patients from healthy controls. The selected 
features were subsequently used in the classification and 
quantitative assessment tasks. An ensemble classifier was 
proposed to distinguish between healthy individuals and those 
with a diagnosis of HD, which significantly improved the 
accuracy of the previously proposed simple SVM classifier 
[13]. Linear regression model was created to generate 
continuous scale sensitive assessment of movement impairment 
in HD, which has not been attempted in previous research.  
In this research, we limited our focus to the upper limbs 
during the performance of a functional task both to minimise 
error in placement of accelerometers during movement and to 
ensure ease of clinical application of the automated assessment 
in the future.   
II. MATERIALS AND METHODS 
A. Participants and Setting 
Participants with manifest HD and healthy controls were 
recruited to this observational study. All participants were 
provided with a written information sheet describing the 
research, and their consent was obtained before any data 
collection. HD participants were eligible if they had a 
genetically confirmed diagnosis of HD with score of four on the 
motor diagnostic confidence scale of the UHDRS, were over 18 
years of age and recruited onto Enroll-HD, which is a global 
observational study that provides researchers with access to 
non-identifiable clinical information (https://www.enroll-
hd.org/). They were not eligible if they were unable to provide 
informed consent. Ethical approval was granted for this study 
by the South East Wales Research Ethics committee (REC 
reference: 14/WA/1195) and Cardiff University School of 
Engineering.  
B. Assessments  
Demographic data including age (years), gender and 
UHDRS-TMS [5] were recorded from the most recent annual 
Enroll-HD assessment. The UHDRS-TMS provides a clinician 
observed rating of oculomotor function, dysarthria, chorea, 
dystonia, rigidity, bradykinesia, balance and gait. Each item 
was rated by a rater certified clinician on a scale of 0-4, where 
0 is equivalent to no impairment. The maximum possible score 
of all items is 124 (indicating maximum disability). For the 
purposes of this study a modified upper limb motor impairment 
score (mULMS) was generated from the UHDRS-TMS as the 
sum of items assessing left and right upper limb dystonia, trunk 
chorea, and left and right upper limb chorea. Thus mULMS can 
vary between zero for no impairment to a maximum of 20 
representing severe motor impairment.  
 
 
Fig. 1 The MBT test enclosed in the case when not in use 
(left) and open ready for testing (right). 
 
All participants completed the Money Box Test (MBT) [13], 
[20] - a functional upper limb dexterity assessment involving a 
series of token transfer tasks (Fig. 1). The tasks increase in 
difficulty (baseline simple, baseline complex and a dual task). 
In the baseline simple task, eight blank tokens of varying size 
are presented and positioned in designated slots, vertically, in 
size order. The participant is asked to pick up each token 
individually with their non-dominant hand, transfer it to their 
dominant hand and place into the moneybox, starting with the 
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largest token and finishing with the smallest. For the baseline 
complex task, a different set of tokens, with one of the eight 
values printed on them (1, 2, 5, 10, 20, 50, 100, and 200) is used.  
In this task, the tokens are positioned in order of size. The 
participant is asked to transfer the tokens into the moneybox in 
decreasing value order. The dual task consisted of the same test 
procedure as the baseline complex, with the participants 
additionally asked to recite the alphabet simultaneously while 
transferring the tokens to the moneybox. 
C. Accelerometes 
Three triaxial GENEactiv accelerometers (Activinsights, UK) 
were placed on the participant during the performance of the 
MBT, one on each wrist to record the acceleration of the hands, 
and one on the chest to capture the movement of the trunk (Fig. 
2). Each GENEactiv sensor incorporates three accelerometers, 
where the accelerometers are orthogonally aligned to each 
other. The technical specifications of the accelerometers are as 
following: unit mass 16g, unit size 43mm x 40mm x 13mm, 
sample frequency up to 100Hz, acceleration range ±8g, where 
g =9.81 m/s2. Before the accelerometers were fixed on the 
participant, their time settings were synchronized with those of 
the computer using GENEactive PC software application. The 
accelerometers did not require any additional calibration. All 
data were recorded at frequency of 100Hz.  
 
 
 
Fig. 2 The placement and orientation of accelerometers on the 
wrists and chest of a participant. In the image, the x-axis is 
red, y-axis is blue and z-axis is green. The z-axis for the chest 
sensor (green) is pointing away from the viewer. 
 
D. Automatic Classification Sysem 
An early version of the system proposed in this article was 
presented in [13]. In comparison to the full system presented in 
this article, the system described in [13] was based on a simple 
SVM classifier and temporal features only and was used to 
distinguish between HD patients and healthy controls. 
The fully developed system presented in this article consists of 
three main modules: signal processing and feature extraction 
including both temporal and frequency domain features, 
ensemble classifier to distinguish between HD patients and 
healthy controls during the performance of three different MBT 
tasks, and a linear regression model to generate continuous 
scale sensitive assessment of movement impairment in HD 
(Fig. 3). In this study, both ensemble classifier and the linear 
regression model are implemented using supervised learning 
techniques. 
E. Signal Processing 
In this part of the system, a range of signal processing 
techniques are applied to the accelerometer data in order to 
extract informative features, which potentially could be used for 
continuous quantification of the movement impairment typical 
of HD, such as chorea and dystonia, i.e. the abruptness and 
irregularity of movement and twisting body movements. Each 
of three MBT tasks consists of eight repeated sub-tasks of 
transferring a coin from its position to the moneybox, which 
results in eight observable cycles in motion acceleration data 
for a healthy person, but not for HD patients, whose motion is 
characterized by jerky, sudden movements (Fig. 4) [20]. Time 
and frequency domain features measuring the degree of 
repeatability, regularity, and recurrence are extracted from the 
accelerometer data as explained in detail below. 
F. Time domain features 
This set of features (Table I) includes several features derived 
directly from the raw accelerometer signals without any 
filtration or down sampling to ensure that no important 
information related to the movement impairment is lost. 
These features include simple time domain features such as 
signal mean and standard deviation as well as correlation 
between the acceleration signals along different axes. Other 
time domain features used in this study are derived using 
Recurrence Quantification Analysis of Nonlinear Dynamical 
Systems (RQA) [21], which quantifies the recurrences of a 
dynamical system. The values of RQA are expected to be higher 
for HD than for healthy participants. In addition, Lyapunov 
exponent (LE) [22] is used to measure the degree of chaos in 
the signal. As the acceleration signals are less regular and more 
chaotic for HD patients, a significant difference between the LE 
values can be expected for these two groups. Sample entropy is 
used to assess the complexity and regularity within the time 
series data, as it measures the degree of dependency of a given 
data point on a number of previous data points [23]. Finally, 
permutation entropy [24] is used to measure the regularity in 
the time series data by measuring the existence or absence of 
permutation patterns within it. 
G. Frequency domain features 
Frequency domain features are expected to change depending 
on the presence of involuntary jerky movements in the 
acceleration data, so short-time Fourier Transform (STFT) is 
employed to transform the acceleration data to frequency 
domain. There are eight clearly observable cycles in the 
acceleration data for a healthy person resulting from the activity 
of transferring eight coins (Fig. 4). On average, for healthy 
volunteers, each of the transfer cycles lasts 2 seconds. 
Therefore, a decision was made to use a sliding window of 2
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Fig. 3 Above: classification system; below: ensemble classifier. 
 
TABLE I.  
TIME DOMAIN FEATURES 
 
Feature No. of attributes per subject Feature description 
Recurrence rate 9 
Recurrence rate in the signal, i.e. 
the probability that any state will 
recur again 
R
QA
 
R_ Entropy 9 Measurement of the recurrence 
structure complexity 
Determinism 9 The ratio of recurrence points 
Average diagonal 
line 9 
Average time that signal 
segments remain the same. 
LE 9 
Lypaunov exponent, measures 
the level of chaos in the time 
series signal 
 
Sample entropy 9 Assesses the complexity of the time series signal 
 
 
Permutation 
entropy 
 
9 Assesses the complexity of the time series signal 
 
Standard deviation 9 The standard deviation of the time series signal 
 
Mean 9 The mean of acceleration signal  
Correlation 
between axes 9 
Correlation between each pair of 
axes for each accelerometer 
 
 
seconds length and 50% overlap for STFT. In this study, a 
simple rectangular window followed by a low-pass filter was 
used. As explained below, only the first five low frequency 
components are to be used in further calculations, and thus 
applying a smoothing window such as Hanning was deemed 
unnecessary. 
Three sets of frequency features are extracted from the result of 
STFT, namely, spectral energy, component entropy, and the 
average magnitudes of each of the first five STFT components 
over all windows in each of the tests. These features were 
chosen as they had been reported to provide good results for 
movement recognition on the basis of accelerometer signals 
 
                      (a) 
 
            (b) 
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Fig. 4 Examples of accelerometer data for the non-dominant 
hand for: (a) healthy control participant; (b) manifest stage HD 
patient. 
 
 
and thus potentially could contain information useful for 
measuring the degree of movement impairment in HD patients 
[25]. Wavelet Packet Decomposition (WPD) is also used to 
extract a number of time-frequency features from the signals. 
The decision to employ WPD was made on the basis of its 
ability to describe signals containing numerous frequency 
changes over time [26]. In this study, the accelerometer signals 
are decomposed into five levels using Daubechies 2 wavelets.  
The six wavelet features used in this study are defined as the 
sum of the absolute values of coefficients at levels 1-5; these 
features were chosen as they have been reported to have good 
ability to capture the patterns of the low frequency movements 
in the accelerometer signals, which should be suitable for HD 
data [24]. Table II shows a summary of the extracted frequency 
domain features.  
 
TABLE II.  
FREQUENCY DOMAIN FEATURES 
 
Feature 
No. of 
attributes 
per subject 
Description of the feature 
Frequency domain 
entropy  
 
         
         9 Entropy of STFT components  
Spectral energy           9 Sum of STFT coefficients  
Average magnitude 
of 5 SFFT  
 
45 
 
The average magnitude of the first 
5 STFT components for each axis 
 
Magnitude 
coefficients of 
wavelet 
 
63 
The sum of squared wavelet 
coefficients from level 1 to 6 
 
Wavelet energy 
9 Sum of squared wavelet 
coefficients 
 
Wavelet entropy 9 Entropy of wavelet component 
 
 
H. Feature selection 
Following the initial feature extraction, when a total of 234 time 
and frequency domain feature values are extracted from the 
signals of the three sensors for each participant and each MBT 
task, a feature selection method is used to select the most 
relevant and non-redundant features for discriminating between 
HD and healthy participants and thus to reduce the 
dimensionality of the data set. In this study the Joint Mutual 
Information Maximisation (JMIM) [27] feature selection 
method is chosen as it relies on an objective function to select 
the most informative features from a set and has been reported 
to outperform the other state of the art methods. Continuous 
features are discretized using Equal Width Discretization 
method (EWD) [28] before JMIM is applied to all features. 
I. Ensemble classifier 
The goal of this part of the system is to distinguish between HD 
patients and healthy participants, for which an ensemble 
classifier is created. A supervised learning approach is followed 
to create an ensemble classifier, the inputs for which are the 
values of the selected features, and the output takes on one of 
the two values: HD or healthy control. To make the classifier 
more sensitive to the detection of HD patients at the early 
manifest stage of HD, the data from all three MBT tasks (if 
available) is used for all HD and healthy participants. For each 
MBT task, a Support Vector Machine (SVM) classifier with 
radial basis function (RBF) kernel [29] is trained using a 
number of the most significant features extracted from the 
corresponding dataset (Fig. 3). Thus the first classifier is trained 
on the selected features for the baseline simple dataset, the 
second classifier is trained on the selected features for the 
baseline complex dataset and the third classifier is trained on 
the selected features for the dual task dataset. Finally, the results 
of the three classifiers are combined in an ensemble classifier. 
Different techniques for combining results of different 
classifiers such as Bayes, majority voting, and decision 
template [30] were tested, from which the majority voting was 
chosen as providing the best results. In some cases, when the 
participant failed to perform the baseline complex or the dual 
task (due to the advanced stage of the disease), the classification 
was performed using only the baseline simple classifier.    
J. Linear regression model 
In this stage, a linear regression model is used to automatically 
generate the Movement Impairment Score (MIS) intended to 
describe the degree of impairment related to the upper limb 
movement. Five of the most significant features extracted from 
the baseline task MBT dataset are used as independent variables 
(inputs) and the mULMS is used as a dependent variable 
(output). SVM linear regression is applied to obtain the 
regression model parameters and leave-one-out cross-
validation is employed to assess the correlation between the 
MIS and the mULMS. 
III. RESULTS 
 
Mean (SD) age in years in HD participants (n=44, 26 males) 
and healthy controls (n=48, 26 males) were 53.49 (13.19) and 
37.38 (13.31) respectively. Mean (SD) scores on the UHDRS-
TMS  and mULMS for HD participants were 36.43(23.16) and 
5.98 (4.17) respectively. Seven HD participants failed to 
perform both the baseline complex and the dual tasks, while 
five other HD participants failed to perform the dual task only. 
The average time taken to perform the test by the HD 
participants was 30.62 seconds. The average time for the 
healthy controls was 13.6 seconds. 
A. Significant features 
The most significant features for discrimination between HD 
and healthy participants were identified using the JMIM 
method for the baseline simple, baseline complex, and dual 
tasks (Tables III-V). The results showed that the recurrence rate 
feature of the non-dominant hand X-axis was significant for 
discriminating between HD patients and healthy controls in all 
three MBT tasks. This can be explained by the fact that most of 
the transfer task was performed by the non-dominant hand with 
the dominant hand remaining close to the moneybox.  The 
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results also showed that time domain features measuring 
regularity, repeatability, and chaos were more significant than 
the frequency domain features, which means that time domain 
features represent the movement patterns specific to chorea and 
dystonia better than other features.  
 
 
 
  
TABLE III 
 
TEN MOST SIGNIFICANT FEATURES FOR DISCRIMINATING BETWEEN HD AND 
HEALTHY CONTROLS IN THE BASELINE SIMPLE TASK 
 
No 
 
Feature 
1 Non-dominant  hand X-axis recurrence rate (RQA) 
2 Non-dominant  hand Y-axis standard deviation 
3 Non-dominant  hand Y-axis recurrence entropy (RQA) 
4 Chest X-axis sample entropy 
5 Dominant hand Z-axis sample entropy 
6 Dominant hand Y-axis mean 
7 Dominant hand Y-axis sample entropy 
8 Dominant hand Y-axis wavelet entropy 
9 Chest correlation between X axis and Z axis 
10 
 
Chest Z-axis sample entropy 
 
 
 
TABLE IV 
TEN MOST SIGNIFICANT FEATURES FOR DISCRIMINATING BETWEEN HD AND 
HEALTHY CONTROLS IN THE BASELINE COMPLEX TASK 
 
No 
 
Feature 
1 Non-dominant hand X-axis recurrence rate 
2 Dominant hand Z-axis sample entropy 
3 Dominant hand Y-axis average diagonal line (RQA) 
4 Dominant hand X-axis CC5 magnitude 
coefficients of wavelet decomposition 
5 Dominant hand Y-axis sample entropy 
6 Dominant hand X-axis Lypaunov exponents 
7 Chest Y-axis sample entropy 
8 Dominant hand Z-axis permutation entropy 
9 Dominant hand X-axis average diagonal line (RQA) 
10 Chest Z-axis mean 
 
 
 
TABLE V 
TEN MOST SIGNIFICANT FEATURES FOR DISCRIMINATING BETWEEN HD AND 
HEALTHY CONTROLS IN THE DUAL TASK 
 
No 
 
Feature 
1 Non-dominant hand X-axis recurrence rate (RQA) 
2 Non-dominant hand Y-axis permutation entropy 
3 Non-dominant hand X-axis average diagonal 
Line (RQA) 
4 Dominant hand Y-axis sample entropy 
5 Dominant hand correlation between Y axis and 
Z axis. 
6 Non-dominant hand  Z-axis mean 
7 Non-dominant hand  Y-axis determinism (RQA) 
8 Chest X-axis recurrence entropy 
9 Chest Z-axis recurrence rate 
10 Chest Y-axis recurrence rate 
 
 
B. Performance of ensemble classifier 
The performance of each classifier for discriminating between 
healthy controls and HD patients was tested separately as well 
as in combination as an ensemble classifier. The ranking of 
features provided by the feature selection method was used to 
find the best subset of features for each classifier. Five folds 
cross-validation was used to train and test the classifiers. This 
means that the data related to different participants was divided 
randomly into five folds (sets of approximately equal size), with 
four folds used for training and the remaining fold used for 
testing. The cross-validation process was repeated five times 
until each fold was used for testing exactly once. Thus in each 
iteration the training and testing data were different. The 
average accuracy, sensitivity, and specificity over five 
iterations were used as the measure of the classification 
performance. 
In the experiment, the first classifier was trained and tested 
using the baseline simple MBT dataset. For this classifier, a 
combination of 43 most significant features produced the best 
performance with accuracy of 91.11%, sensitivity of 90.38%, 
and specificity of 92.11%. The second classifier was trained and 
tested using the baseline complex MBT dataset, for which the 
best performance was achieved using only three features, with 
the classification accuracy in discriminating between HD 
patients and healthy controls of 93.1%, and sensitivity and 
specificity of 87.76% and 100% respectively. Finally, the third 
classifier was trained and tested using the dual task MBT 
dataset. The best accuracy of 87.8% was achieved using 49 
most significant features. The corresponding values for 
sensitivity and specificity were 81.82%, and 94.74% 
respectively.  
 
Fig. 5. The output of the ensemble classifier vs the mULMS 
for HD patients. 
 
The ensemble classifier obtained by majority voting between 
the above three classifiers achieved the accuracy of 98.8%, 
100% specificity and 97.7% sensitivity with only one out of 44 
HD participants misclassified as a healthy control, and all 
healthy controls classified correctly. This compares well to the 
accuracy of 86.4% reported in [13] in a similar experiment. The 
misclassified HD case had a very low mULMS equal to 2, 
indicative of very subtle motor symptoms, which can explain 
the error, although 11 more patients with the mULMS of 2 or 
lower were classified correctly as HD patients (Fig. 5).  
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Considering that the features related to the chest sensor often 
appeared at the bottom of Tables III-V, it was decided to 
evaluate the performance of the ensemble classifier without the 
features related to the chest sensor in order to test the hypothesis 
that the chest sensor was not needed to achieve accurate 
classification of HD and healthy control participants.  
In this experiment, the best accuracy for the baseline simple 
MBT classifier was achieved using 60 most significant features. 
For the baseline complex MBT classifier, the best accuracy was 
achieved using 49 most significant features, and the best 
accuracy for the dual task MBT classifier was achieved using 
25 most significant features. The achieved accuracy, sensitivity 
and specificity for the ensemble classifier were 86.52%, 
83.78% and 88.46%, which is considerably lower than in the 
previous experiment, and thus the importance of the chest 
sensor for correct discrimination between healthy and HD 
participants was demonstrated. 
 
C. Evaluation of the linear regression model 
The data from baseline simple MBT task for HD patients were 
used in a linear regression model of movement impairment in 
order generate an automatic MIS for new HD patients.  The 
SVM regression algorithm with a linear kernel was used for this 
purpose [29]. Five most significant features from the baseline 
simple MBT classifier were used as independent variables for 
the regression model. Leave one out cross validation was used 
to evaluate the correlation between the automatically produced 
MIS and the mULMS of five chosen items related to chorea and 
dystonia.  
The Pearson correlation coefficient r between the automatic 
MIS and the mULMS was 0.77, which corresponds to r2 = 0.59 
and r2adj = 0.53 with a p-value < 0.01 indicating its high 
statistical significance. In addition, the mean absolute error 
(MAE) [31] between the automatic MIS and mULMS was 2.11, 
which corresponds to the normalised MAE of 12.41% with 
respect to the maximum score of 17 in the sample, thus showing 
an ability to predict the clinician rated upper limb chorea and 
dystonia scores with some accuracy. Fig. 6 shows the values of 
the mULMS and the corresponding automatic MIS generated 
by the linear regression model trained on all HD data apart from 
one of the samples used for testing.  
 
 
 
Fig.6 mULMS and corresponding automatic MIS generated 
by the linear regression model trained on all HD baseline 
simple task data apart from one of the samples used for 
testing. 
IV. DISCUSSION 
Here we present a system for an objective and continuous 
assessment of motor impairment during a novel upper limb task 
for HD patients. The system is based on data collected from tri-
axial accelerometers, which were worn during the performance 
of a recently proposed MBT assessment of bilateral, upper 
motor function. Signal processing and machine learning 
methods were applied to the recorded accelerometer signals in 
order to produce an automatic MIS intended to reflect the 
degree of the movement impairment during the performance of 
the MBT.  
A number of features, potentially useful for quantification of 
the movement impairment, were extracted from the 
accelerometer data and their significance in the discrimination 
task between healthy controls and HD participants was 
assessed. The results showed that temporal features were more 
important than frequency features, and in particular, features 
related to the non-dominant hand were just as significant if not 
more significant than those extracted from the data related to 
the dominant hand. 
Before proceeding to the stage of generating an automatic 
MIS for HD patients, the extracted features were tested in a 
simpler discriminative task of differentiating between HD 
patients and healthy controls, in which very encouraging results 
were achieved, further proving that the extracted features 
captured the information relevant to motion impairment of HD 
patients. In this stage, three classifiers, one for each MBT task, 
were trained and tested, with the complex baseline classifier 
producing the best performance among the three classifiers. The 
results produced by the ensemble classifier demonstrate the 
advantage of using three tasks of increasing difficulty when 
performing MBT, with the complex baseline and dual task 
classifiers improving the accuracy of the baseline classifier 
when their results were combined. Given these results, we do 
not believe that the difference in ages between the HD and the 
healthy control groups had a detrimental effect on the ability of 
the assembly classifier to determine the group correctly on the 
basis of the accelerometer data, however will confirm this in 
subsequent studies. Furthermore, the importance of the chest 
sensor was assessed by removing the features related to this 
sensor from the dataset and repeating the above experiments 
and cross-validation using the reduced dataset. The results 
demonstrated significant increase in misclassifications 
indicating that the chest sensor is important in the assessment 
of HD movement impairment.   
The system also produces a continuous value movement 
impairment score (MIS) that is well correlated with the clinician 
rated mULMS reflecting upper body chorea and dystonia. From 
a clinical perspective this is an exciting development in that the 
novel MIS provides a quantitative representation of chorea and 
dystonia of the upper limb in HD that traditionally is very 
difficult to rate reliably. The correlation between the automatic 
MIS and the mULMS demonstrates the viability of using the 
MIS for monitoring the progression of the movement disorders. 
First Author et al.: Title 3 
Nonetheless, further validation of the proposed system is 
required. Special care will need to be taken when comparing the 
automatic MIS and mULMS due to the subjectivity of the latter. 
There is a number of strategies which can be followed to 
address this issue, including testing intra- and inter-rater 
reliability. 
V. CONCLUSIONS 
The approach presented in this study demonstrates the 
possibility of objective, consistent and sensitive assessment of 
the HD movement impairment using the MBT and three low-
cost tri-axial accelerometers. The initial application of this test 
has been in HD: a highly characterised, single gene 
neurodegenerative disease. Given these promising results, we 
are now working to establish proof of concept in other 
neurological conditions such as Parkinson’s disease, tremor and 
dystonia. Future research will focus on combining acceleration 
with orientation data to improve the performance of the system 
and to expand the number of neurological movement disorders 
the system could assess. 
ACKNOWLEDGMENT 
Subsequent to the development of this project, the MBT test 
has been renamed to the Clinch Token Transfer Test (C3t) and 
undergone some minor amendments to develop an advanced 
prototype for full evaluation in a clinical setting. Future 
publications of this test will be in relation to the C3t.  We would 
like to acknowledge Cheney Drew, Samuel Woodgate, Khalid 
Hamandi, Kathryn Peall, Laura Bunting and Katy Hamana, all 
of whom are working with us to progress the C3t test towards 
broader clinical evaluations. 
 
References 
[1] F. O. Walker, “Huntington's disease,”  The Lancet, vol. 369(9557), pp. 
218-228, 2007. 
[2] D. W. Weir, A. Sturrock, B. R. Leavitt, “Development of biomarkers for 
Huntington's disease,” The Lancet Neurology, vol. 10, no. 6, pp. 573-590,  
2011. 
[3] N. Georgiou, J. L. Bradshaw, J. G. Philips, E. Chiu, J. A. Bradshaw, 
“Reliance on advance information and movement sequencing in 
Huntington’s disease,” Mov Disord., vol. 10, no. 4, pp. 472-481, 1995. 
[4] N. E. Fritz, K. Hamana, M. Kelson, A. Rosser, M. Busse, L. Quinn, 
“Motor-cognitive dual-task deficits in individuals with early-mid stage 
Huntington disease,” Gait & Posture, vol. 49, pp. 283-289, 2016. 
[5] Huntington Study Group. “Unified Huntington’s Disease Rating Scale: 
reliability and consistency,” Mov Disord., vol. 11, no. 2, pp. 136-142, 
1996. 
[6] A. L. Vaccarino et al. “Assessment of motor symptoms and functional 
impact in prodromal and early Huntington disease,” Version 2, PLoS 
Currents: Huntington Disease, Jun. 2011. 
[7] S. Lee, Y. S. Lee, J. Kim, “Automated Evaluation of Upper-Limb Motor 
Function Impairment Using Fugl-Meyer Assessment”, IEEE Trans 
Neural Syst Rehabil Eng., vol. 26, no. 1, pp. 125-134, 2018. 
[8] A. Mannini, D. Trojaniello, U. Della Croce, A. M. Sabatini, “Hidden 
Markov model-based strategy for gait segmentation using inertial sensors: 
application to elderly, hemiparetic patients and Huntington’s disease 
patients,” presented at the Annual Int. Conf. IEEE Eng. Med. Biol. Soc., 
Milan, Italy, 2015.  
[9] A. Mannini, D. Trojaniello, A. Cereatti, A. M. Sabatini, “A machine 
learning framework for gait classification using inertial sensors: 
Application to elderly, post-stroke and Huntington’s disease patients,” 
Sensors, vol. 16, no. 1, pp. 134–148, 2016.   
[10] K. L. Andrzejewski et al., “Wearable sensors in Huntington disease : a 
pilot study”, Journal of Huntingtons Dis., vol. 5, no. 2, pp. 199-206, 2016.   
[11] R. Reilmann, S. Bohlen, F. Kirsten, E. B. Ringelstein, H. W. Lange, 
“Assessment of involuntary choreatic movements in Huntington's 
disease--toward objective and quantitative measures,” Mov Disord., vol. 
26, no. 12, pp. 2267-73, 2011. 
[12] K. E. Kotschet, S. Osborn, M. K. Horne, “Automated assessment of 
bradykinesia and chorea in Huntington's disease [abstract]”, Mov Disord., 
vol. 29, no. S1, p. 566, 2014. 
[13] M. Bennasar Y. Hicks, S. Clinch, P. Jones, A. Rosser, M. Busse, 
“Huntington’s disease assessment using tri axis accelerometers,” 
presented at 20th Int. Conf. Knowledge Based and Int. Inf. and Eng. 
Systems, York, UK, 2016. 
[14] O. Martinez-Manzanera. E. Roosma, M. Beudel, R. W. K. Borgemeester, 
T. van Laar, N. M. Mauritis, “A method for automatic, objective and 
continuous scoring of bradykinesia,” presented at the IEEE Int. Conf. 
Body Sensor Networks, Cambridge, MA, USA, 2015. 
[15] O. Martinez-Manzanera, E. Roosma, M. Beudel, R. W. K. Borgemeester, 
T. van Laar, N. M. Maurits, “A method for automatic and objective 
scoring of bradykinesia using orientation sensors and classification 
algorithms,” IEEE Trans. Biomed. Eng., vol. 63, no. 5, pp. 1016–1024, 
2016. 
[16] K. J. Kubota, J. A. Chen, M. A. Little MA, “Machine learning for large-
scale wearble sensor data in Parskinson disease: concepts, promises, 
pitfalls and futures,” Mov Disord., vol. 31, no. 9, pp. 1314–1326, 2016. 
[17] K. Yang et al. “Objective and quantitative assessment of motor function 
in Parkinson’s disease – from perspective of practical applications,” Ann 
Transl Med, vol. 4, no. 5, p. 90, 2016. 
[18] H. Hasan, D. S. Althauda, T. Foltynie, A. J. Noyce, “Technologies 
assessing limb bradykinesia in Parkinson’s disease,” J. Parkinson's Dis., 
vol. 7, no. 1, pp. 65-77, 2017. 
[19] Q. W. Oung et al., “Technologies for assessment of motor disorders in 
Parkinson’s disease: a review,” Sensors, vol. 15, no. 9, pp. 21710-21745, 
2016. 
[20] S. P. Clinch, M. Busse, M. J. Lelos, A. E. Rosser, “Rethinking Functional 
Outcome Measures: The Development of a Novel Upper Limb Token 
Transfer Test to Assess Basal Ganglia Dysfunction”, Front. Neurosci., 
vol. 12, p. 366, 2018. 
[21] C. L. Webber,  and J. P. Zbilut. (2005, October 5). “Recurrence 
quantification analysis of nonlinear dynamical systems,” in Tutorials in 
Contemporary Nonlinear Methods for the Behavioral Sciences. [Online]. 
Available: www.nsf.gov/publications/pub_summ.jsp?ods_key=nsf05057 
[22] A. Wolf, J. B. Swift, H. L. Swinney, J. A. Vastano, “Determining 
Lyapunov exponents from a time series,” Physica D: Nonlinear 
Phenomena, vol. 16, no 3, pp.285-317, 1985. 
[23] H. B. Xie W. X. He, H. Liu, “Measuring time series regularity using 
nonlinear similarity-based sample entropy,” Physics Letters A,  vol. 372, 
no. 48, pp. 7140-7146, 2008. 
[24] M. Riedl, A. Muller, N. Wessel, “Practical considerations of permutation 
entropy,” The Eur. Phys. J. Special Topics, vol. 222, no. 2, pp. 249-262, 
2013. 
[25] S. J. Preece, J. Y. Goulermas, L. P. J. Kenney, D. Howard,  “A comparison 
of feature extraction methods for the classification of dynamic activities 
from accelerometer data,” IEEE Trans. Biomed. Eng., vol. 56, no. 3, pp. 
871–879, 2009.  
[26] X. Ren,  W. Ding, S. E. Crouter, Y. Mu, R. Xie, “Activity recognition and 
intensity estimation in youth from accelerometer data aided by machine 
learning,” Appl Intell, vol. 45, no. 2, pp. 512–529, 2016.  
[27] M. Bennasar, Y. Hicks, R. Setchi, “Feature selection using joint mutual 
information maximisation,” Expert Systems with Applications,  vol. 42, 
no. 22, pp. 8520–8532,  2015. 
[28] J. Dougherty, R. Kohavi, M. Sahami, “Supervised and unsupervised 
discretization of continuous features,” in Proc. 12th Int. Conf. Machine 
Learning, San Francisco, pp. 194-202, 1995. 
[29] S. I. Amari and S. Wu, “Improving support vector machine classifiers by 
modifying kernel functions,” Neural Networks, vol. 12, no. 6, pp. 783-
789, Jul. 1999. 
[30] T. G. Dietterich, “Ensemble methods in machine learning,” presented at   
the First Int. Workshop Multiple Classifier Systems, pp. 1-15, Jun. 2000. 
[31] T. Chai and  R. R. Draxler, “Root mean square error (RMSE) or mean 
absolute error (MAE)?–Arguments against avoiding RMSE in the 
literature,” Geoscientific Model Development,  vol. 7, no. 3, pp.1247-
1250, Jun. 2014. 
 
